First Time Loading...

Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3

Watchlist Manager
Oncoclinicas do Brasil Servicos Medicos SA Logo
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Watchlist
Price: 6.28 BRL -15.93% Market Closed
Updated: May 9, 2024
Section:
 

Relative Value

The Relative Value of one ONCO3 stock under the Base Case scenario is 23.96 BRL. Compared to the current market price of 6.28 BRL, Oncoclinicas do Brasil Servicos Medicos SA is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ONCO3 Relative Value
Base Case
23.96 BRL
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
91
vs Industry
76
Median 3Y
1
Median 5Y
1
Industry
2.4
Forward
0.5
More Details
14.3
P/E
P/E
Price to Earnings
14.3
vs History
54
vs Industry
35
Median 3Y
21.6
Median 5Y
21.6
Industry
23.4
Forward
8.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
29
Median 3Y
-14
Median 5Y
-14
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-13.1
Median 5Y
-13.1
Industry
23.2
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
74
vs Industry
55
Median 3Y
2.1
Median 5Y
2.1
Industry
2.3
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
80
vs Industry
64
Median 3Y
1.5
Median 5Y
1.5
Industry
2.5
Forward
0.9
More Details
3.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.4
vs History
80
vs Industry
56
Median 3Y
4.3
Median 5Y
4.3
Industry
5.3
More Details
6.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.4
vs History
85
vs Industry
43
Median 3Y
9.1
Median 5Y
9.1
Industry
12.6
Forward
3.6
More Details
8.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.6
vs History
82
vs Industry
41
Median 3Y
12.2
Median 5Y
12.2
Industry
17.2
Forward
5.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
19
Median 3Y
-21.2
Median 5Y
-21.2
Industry
15.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-19.1
Median 5Y
-19.1
Industry
19.8
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
65
vs Industry
64
Median 3Y
1
Median 5Y
1
Industry
2
More Details

Multiples Across Competitors

ONCO3 Competitors Multiples
Oncoclinicas do Brasil Servicos Medicos SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
3.2B BRL 0.6 14.3 6.4 8.6
US
Cigna Corp
NYSE:CI
98.7B USD 0.5 27.3 9.8 13
US
Cigna Group
XMUN:CGN
91.3B EUR 0.5 27.1 9.8 12.9
US
CVS Health Corp
NYSE:CVS
68.7B USD 0.2 9.4 8.6 8.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
16B EUR 0.7 -27 10.2 22.8
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.2 11.9 18
US
Quest Diagnostics Inc
NYSE:DGX
15.1B USD 1.6 17.9 10.7 14.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.3B EUR 0.6 22.7 6.8 16.1
US
DaVita Inc
NYSE:DVA
11.9B USD 1 14.6 8.2 11.8
DE
Fresenius Medical Care AG
XMUN:FME
11B EUR 0.6 22 6.7 15.9
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
ONCO3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONCO3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONCO3 stock valuation using valuation multiples.
Wall Street Estimates
ONCO3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONCO3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.